https://www.ndtvprofit.com/business/ipca-laboratories-faces-us-fda-scrutiny-over-three-lapses-at-silvassa-facility-bq-exclusive?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
U.S. FDA inspected the Silvassa facility from April 18 to April 26 and issued Form 483 with three observations.